| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
4 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
8 |
| Net Income (TTM) (Millions $) |
-12 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Genetic Technologies Ltd is a biotechnology company based in Australia. The company primarily focuses on developing and commercializing genetic testing solutions that help improve the diagnosis and management of various diseases and conditions. They specialize in utilizing genetic markers to predict an individual's risk for developing certain diseases, such as cancer and cardiovascular diseases.
Genetic Technologies offers a range of genetic tests that are designed to provide personalized risk assessments and guide healthcare decisions. Their flagship product, BREVAGenplus, is a non-invasive test that assesses a woman's risk for developing breast cancer based on genetic markers and personal risk factors.
The company also provides testing services for other genetic conditions, including colorectal cancer, type 2 diabetes, obesity, and cardiovascular diseases. They collaborate with healthcare professionals and researchers to continuously improve their testing methodologies and expand their test portfolio.
In addition to their genetic testing services, Genetic Technologies also offers a range of research and development services to biotechnology and pharmaceutical companies. Their expertise in genetic testing and analysis allows them to assist partners in identifying and validating potential targets for drug development.
Overall, Genetic Technologies Ltd aims to revolutionize healthcare by harnessing the power of genetics to provide personalized risk assessments and improve patient outcomes.
Company Address: 60-66 Hanover Street Fitzroy 3065
Company Phone Number: 3 8412 7000 Stock Exchange / Ticker: GENE
|
%